Translation of ischemic preconditioning to the patient: Prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy

Stroke

Volumn 35, Issue 11 SUPPL. 1, 2004, Pages 2687-2689

  Ratan, Rajiv R ^a,b   Siddiq, Ambreena ^a   Aminova, Leila ^a   Lange, Philipp S ^a   Langley, Brett ^a   Ayoub, Issam ^a   Gensert, JoAnn ^a   Chavez, Juan ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Burke Cornell Medical Research Institute   (United States)

Author keywords

Acute care; Hypoxia; Ischemia; Stroke; Transcription

Indexed keywords

2 OXOGLUTARIC ACID; CHELATING AGENT; COBALT CHLORIDE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; EMOXIPIN; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; IRON; MIMOSINE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; RNA POLYMERASE II; VASCULOTROPIN;

BRAIN HYPOXIA; CONFERENCE PAPER; ENZYME INHIBITION; ENZYME STABILITY; GENE EXPRESSION; GENE TARGETING; HEART INFARCTION PREVENTION; HOMEOSTASIS; HYDROXYLATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STROKE;

ANIMALS; BRAIN ISCHEMIA; CELL HYPOXIA; CEREBROVASCULAR ACCIDENT; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING; NEUROPROTECTIVE AGENTS; NUCLEAR PROTEINS; PROCOLLAGEN-PROLINE DIOXYGENASE; TRANSCRIPTION FACTORS;

EID: 7644229277     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000143216.85349.9e     Document Type: Conference Paper

References (28)

1. Muir KW. Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design. Stroke. 2002;33:1545-1550.
2. Lyden PD, Jackson-Friedman C, Shin C, Hassid S. Synergistic combinatorial stroke therapy: a quantal bioassay of a GABA agonist and a glutamate antagonist. Exp Neurol. 2000;163:477-489.
3. Aronowski J, Strong R, Shirzadi A, Grotta JC. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke. 2003;34:1246-1251.
4. Fisher M, Ratan R. New perspectives on developing acute stroke therapy. Ann Neurol. 2003;53:10-20.
5. Pong K. Ischaemic preconditioning: therapeutic implications for stroke? Expert Opin Ther Targets. 2004;8:125-139.
6. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehulsing GJ, Brunecker P, Muller B, Banasik A, Amberger N, Wernecke KD, Siebler M, Rother J, Villringer A, Weih M. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke. 2004;35:616-621.
7. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 2003;362:1028-1037.
8. Monge C, Leon-Velarde F. Physiological adaptation to high altitude: oxygen transport in mammals and birds. Physiol Rev. 1991;71:1135-1172.
9. Jelkmann W. Erythropoietin. J Endocrinol Invest. 2003;26:832-837.
10. Harik SI, Hritz MA, LaManna JC. Hypoxia-induced brain angiogenesis in the adult rat. J Physiol. 1995;485(Pt 2):525-530.
11. Boero JA, Ascher J, Arregui A, Rovainen C, Woolsey TA. Increased brain capillaries in chronic hypoxia. J Appl Physiol. 1999;86:1211-1219.
12. Xu F, Severinghaus JW. Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema. J Appl Physiol. 1998;85:53-57.
13. Waltenberger J, Kranz A, Beyer M. Neovascularization in the human heart is associated with expression of VEGF-A and its receptors Flt-1 (VEGFR-1) and KDR (VEGFR-2). Results from cardiomyopexy in ischemic cardiomyopathy. Angiogenesis. 1999;3:345-351.
14. Webster KA. Evolution of the coordinate regulation of glycolytic enzyme genes by hypoxia. J Exp Biol. 2003;206:2911-2922.
15. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell. 2001;107:1-3.
16. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett. 1994;168:221-224.
17. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol. 2000;48:285-296.
18. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci. 2002;22:10291-10301.
19. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin Cell Dev Biol. 2002;13:29-37.
20. Maxwell PH. HIF-1's relationship to oxygen: simple yet sophisticated. Cell Cycle. 2004;3:156-159.
21. Freeman RS, Hasbani DM, Lipscomb EA, Straub JA, Xie L. SM-20, EGL-9, and the EGLN family of hypoxia-inducible factor prolyl hydroxylases. Mol Cells. 2003;16:1-12.
22. Dalgard CL, Lu H, Mohyeldin A, Verma A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem J. 2004;380:419-424.
23. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. C. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43-54.
24. Zaman K, Ryu H, Hall D, O'Donovan K, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL, Ratan RR. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21 (wafl/cipl), and erythropoietin. J Neurosci. 1999;19:9821-9830.
25. Goswami T, Rolfs A, Hediger MA. Iron transport: emerging roles in health and disease. Biochem Cell Biol. 2002;80:679-689.
26. Hurn PD, Koehler RC, Blizzard KK, Traystman RJ. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke. 1995;26:688-694; discussion 694-695.
27. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A. 2000;97:9082-9087.
28. Halterman MW, Miller CC, Federoff HJ. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci. 1999;19:6818-6824.